Cargando…
Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2/glycolysis signaling: Saikosaponin D reverses gemcitabine resistance
Intrahepatic cholangiocarcinoma (iCCA) is a highly fatal malignancy with rapidly increasing incidence and mortality worldwide. Currently, gemcitabine-based systemic chemotherapy is the main clinical therapeutic regimen; however, its efficacy is poor, and its mechanism has not been elucidated. In thi...
Autores principales: | He, Hui, Guo, Jiaqi, Hu, Yunxiang, Zhang, Han, Li, Xinyang, Zhang, Jian, Jin, Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520481/ https://www.ncbi.nlm.nih.gov/pubmed/37489008 http://dx.doi.org/10.3724/abbs.2023040 |
Ejemplares similares
-
Formulations, Hemolytic and Pharmacokinetic Studies on Saikosaponin a and Saikosaponin d Compound Liposomes
por: Zhang, Guo-Song, et al.
Publicado: (2015) -
Chemotherapeutic Potential of Saikosaponin D: Experimental Evidence
por: Manoharan, Suryaa, et al.
Publicado: (2022) -
Facile Synthesis of Saikosaponins
por: Wang, Ziqiang, et al.
Publicado: (2021) -
Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics
por: Zhou, Piao, et al.
Publicado: (2021) -
Interaction between Saikosaponin D, Paeoniflorin, and Human Serum Albumin
por: Liang, Guo-Wu, et al.
Publicado: (2018)